LAS VEGAS, Nevada — Mesalamine improved abdominal pain and stool consistency in patients with irritable bowel syndrome with diarrhea, according to a study presented here at the American College ...

One study presented October 22 found that mesalamine granules, an anti-inflammatory drug used to treat ulcerative colitis, improved abdominal pain and stool consistency in diarrhea-predominant IBS.

One study, titled “Mesalamine Granules 1500 mg Once daily for 12 Weeks Provides Adequate Relief of IBS Symptoms in Irritable Bowel Syndrome with Diarrhea: Results from a Phase 2 Trial” and conducted ...

Mesalamine Linked To Cancer Protection For High Risk Inflammatory Bowel Disease Patients Date: October 15, 2007 Source: American College of Gastroenterology Summary: Mesalamine use among patients ...

October 17, 2007 (Philadelphia) — Mesalamine use in patients with inflammatory bowel disease (IBD) is associated with a significant risk reduction in colorectal cancer, a single-center study ...

“Given the minimal adverse events, we recommend that curcumin be considered as an adjunct to mesalamine in the treatment of UC.” Adjunctive therapy with curcumin was found to provide a greater ...

SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than twice as likely to receive mesalamine compared with younger patients, according to ...

All also began to receive 1.2 g of oral mesalamine per day or had their dose increased by 1.2 g per day. Patients were assessed clinically at 0, 2, 4, and 12 weeks and by sigmoidoscopy and biopsy ...

Mesalamine Did Not Prevent Recurrent Diverticulitis in Phase 3 Controlled Trials – Gastroenterology Currently there is no treatment for the prevention of diverticulitis recurrence, although ...

One study presented today found that mesalamine granules, an anti-inflammatory drug used to treat ulcerative colitis, improved abdominal pain and stool consistency in diarrhea-predominant IBS.

October 15, 2007, Philadelphia, PA – Researchers found that mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when ...

Patients with IBS-D showed a statistically significant improvement in abdominal pain and diarrhea after a 12-week course of mesalamine granules (1500 mg), a form of mesalamine or 5-aminosalicylic ...